EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Analysis of Serum and Urinary Metabolites for Early Chronic Kidney Disease

Mihaela-Roxana Glavan, Carmen Socaciu iD, Andreea Iulia Socaciu, Oana Milas, Florica Gadalean, Octavian M Cretu, Adrian Vlad iD, Danina M Muntean, Flaviu Bob, Anca Suteanu, Dragos Catalin Jianu iD, Maria Stefan iD und 3 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26072862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mihaela-Roxana Glavan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II-Nephrology, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timișoara, Romania. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Metabolomics, Metabolome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Victor Babeș" University of Medicine and Pharmacy, Faculty of Medicine, Timișoara, Romania, “Victor Babeș” University of Medicine and Pharmacy, Faculty of Medicine, Timișoara, Romania, Centre for Molecular Research in Nephrology and Vascular Disease, “Victor Babeș” University of Medicine and Pharmacy, Faculty of Medicine, Timișoara, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) has become one of the most rapidly advancing diseases of the century, contributing significantly to increased mortality and morbidity. Metabolomics presents a promising approach to understanding CKD pathogenesis and identifying novel biomarkers for early diagnosis. This study evaluated serum and urine metabolomic profiles in CKD patients with declining glomerular filtration rates (eGFR). Using targeted metabolomics, we quantified seven potential metabolites in blood and urine samples from 20 healthy individuals and 99 CKD patients staged by eGFR according to the KDIGO guidelines. The analysis was conducted using ultra-high performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight mass spectrometry. The metabolites investigated included L-phenylalanine, L-methionine, arginine, indoxyl sulfate, kynurenic acid, and L-acetylcarnitine. Quantitative assessments were performed using pure standards and validated through methods such as the limit of detection (LOD) and limit of quantification (LOQ). The findings identified potential biomarkers for early CKD diagnosis: in serum, L-phenylalanine, L-methionine, arginine, kynurenic acid, and indoxyl sulfate, while L-acetylcarnitine was significant in urine. These biomarkers could provide valuable insights into CKD progression and support in developing more effective diagnostic tools for early intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicMetabolomicsMetabolomeHumansMaleBiomarkersFemaleMiddle AgedAgedAdultGlomerular Filtration RateEarly DiagnosisKynurenic AcidChromatography, High Pressure LiquidArginineCase-Control Studies

Stichwörter der Autor:innen

acylcarnitinesamino acidsbiomarkerschronic kidney diseasemetabolomicsuremic toxins

Substanzen

BiomarkersKynurenic AcidArginine

Autor:innen und Institutionen

  • Department of Internal Medicine II-Nephrology, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timișoara, Romania.
  • Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
  • Research Center for Applied Biotechnology and Molecular Therapy BIODIATECH, SC Proplanta, Str. Trifoiului 12G, 400478 Cluj-Napoca, Romania.
  • Department of Occupational Health, University of Medicine and Pharmacy "Iuliu Haţieganu", Str. Victor Babes 8, 400347 Cluj-Napoca, Romania.
  • Department of Surgery-Surgical Semiotics, "Victor Babeş" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timişoara, Romania.
  • Department of Internal Medicine II-Diabetes and Metabolic Diseases, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timișoara, Romania.

ORCID-Profile: Carmen Socaciu, Adrian Vlad, Dragos Catalin Jianu, Maria Stefan, Lavinia Marcu, Ligia Petrica

Förderung

  • "Victor Babeș" University of Medicine and Pharmacy, Faculty of Medicine, Timișoara, Romania
  • “Victor Babeș” University of Medicine and Pharmacy, Faculty of Medicine, Timișoara, Romania
  • Centre for Molecular Research in Nephrology and Vascular Disease, “Victor Babeș” University of Medicine and Pharmacy, Faculty of Medicine, Timișoara, Romania

Zitieren

APA

Glavan, M. R., Socaciu, C., Socaciu, A. I., Milas, O., Gadalean, F., Cretu, O. M., Vlad, A., Muntean, D. M., Bob, F., Suteanu, A., Jianu, D. C., Stefan, M., Marcu, L., Ienciu, S., & Petrica, L. (2025). Targeted Analysis of Serum and Urinary Metabolites for Early Chronic Kidney Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072862

Vancouver

Glavan MR, Socaciu C, Socaciu AI, Milas O, Gadalean F, Cretu OM, et al. Targeted Analysis of Serum and Urinary Metabolites for Early Chronic Kidney Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072862

BibTeX
@article{Glavan2025,
  author = {Glavan, Mihaela-Roxana and Socaciu, Carmen and Socaciu, Andreea Iulia and Milas, Oana and Gadalean, Florica and Cretu, Octavian M and Vlad, Adrian and Muntean, Danina M and Bob, Flaviu and Suteanu, Anca and Jianu, Dragos Catalin and Stefan, Maria and Marcu, Lavinia and Ienciu, Silvia and Petrica, Ligia},
  title = {Targeted Analysis of Serum and Urinary Metabolites for Early Chronic Kidney Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26072862}
}
Kostenlos starten →